DELHI COMMISSION FOR PROTECTION OF CHILD RIGHTSversusUNION OF INDIA AND ANOTHER
- Citation
- 2022 INSC 98
- Decided
- 25 January 2022
- Disposal
- Disposed off
- Bench
- D Y CHANDRACHUD
Holding
The Court held that the issues raised are matters of policy and expert determination and therefore cannot be decided by the Court without such expertise, directing the Union to refer the suggestions to the appropriate expert groups.
Summary
The Delhi Commission for Protection of Child Rights filed a writ petition under Article 32 seeking that pregnant women and lactating mothers be classified as a high‑risk category for COVID‑19 vaccination and that specific measures such as priority slots, a dedicated registry, and modifications to the Co‑WIN portal be introduced. The Union Government responded that vaccination for these groups had already been approved based on expert advice from NTAGI and NEGVAC, and that existing guidelines already provide for voluntary verbal declaration, AEFI surveillance, and free treatment. The petitioner urged further steps including mandatory declaration at registration, targeted tracking, and public data publication. The Court observed that these matters involve policy decisions and technical expertise beyond its purview and therefore should be examined by the expert groups already constituted by the Government. Consequently, the Court directed the Union to place the petitioner’s suggestions before the relevant expert bodies and disposed of the petition without issuing any substantive direction.
Issues considered
- Whether the Court can direct the Union Government to categorise pregnant women and lactating mothers as a high‑risk group for COVID‑19 vaccination and implement specific procedural measures.
- Whether the Court can mandate modifications to the Co‑WIN portal and the publication of adverse event data for these groups.
Subjects
Judgment
908 SUPREME COURT
[2022]REPORTS
2 S.C.R. 908 [2022] 2 S.C.R.
A DELHI COMMISSION FOR PROTECTION OF CHILD RIGHTS
v.
UNION OF INDIA AND ANOTHER
(Writ Petition (Civil) No 572 of 2021)
B JANUARY 25, 2022
[DR. DHANANJAYA Y CHANDRACHUD AND
SANJIV KHANNA, JJ.]
Covid-19 vaccination: Vaccination of Pregnant Women and
Lactating Mothers – Petitioner seeking categorization of pregnant
C
women and lactating mothers as belonging to the high risk category
for the purposes of vaccination – Certain suggestions made by
petitioner raised issues of policy – The same required the government
to take decision, bearing in mind welfare, safety and dignity of
such class of women – The suggestions made by the petitioner
D involved application of domain knowledge by experts in the area –
Court not in a position to take the decision unaided by an expert
determination – Union Government to place the matter before duly
constituted expert group to evaluate the suggestions – Writ petition
disposed of.
E CIVIL ORIGINAL JURISDICTION: Writ Petition (Civil) No.
572 of 2021.
(UNDER ARTICLE 32 OF THE CONSTITUTION OF INDIA)
Ms. Vrinda Grover, Kumar Shanu, Soutik Banerjee, Ms. Ayushi
Rajput, Ms. Rangoli Seth, Prateek K Chadha, Advs. for the Petitioner.
F
Ms. Aishwarya Bhati, ASG, Gurmeet Singh Makker, Rajat Nair,
Kanu Agrawal, Ms. Deepabali Dutta, Ketan Paul, Advs. for the
Respondents.
Nilesh C. Ojha, Prem Sunder Jha, Ishwarlal S. Agarwal, Ms. Dipali
G N. Ojha, Pratik Jain Saklecha, Shivam Mehra, Abhishek Mishra, Ms.
Sidhi A. Dhamnaskar, Ms. Snehal S. Surve, Ms. Poonam S. Rajbhar,
Ms. Deepika G. Jaiswal, Mangesh B. Dongre, Pritam Bishwas, Anant
Misra, Advs. for the Intervener.
H
908
DELHI COMMISSION FOR PROTECTION OF CHILD RIGHTS v. UNION OF 909
INDIAAND ANOTHER
The Judgment of the Court was delivered by A
DR. DHANANJAYA Y CHANDRACHUD, J.
1. These proceedings under Article 32 of the Constitution have
been instituted by the Delhi Commission for Protection of Child Rights 1.
The specific reliefs which have been sought concern the need to provide
effective access to vaccination to pregnant women and lactating mothers. B
These reliefs can broadly be summarized as follows:
(i) Categorization of pregnant women and lactating mothers
as belonging to the high risk category to be given priority in
vaccination;
C
(ii) Their inclusion in the vaccination drives and setting up of a
task force to operationalize a standard operating procedure 2
for monitoring of their health post vaccination;
(iii) Developing educational materials and SOPs for women
belonging to this group to understand the effects of D
vaccination and ensure informed consent;
(iv) Creation of a registry for vaccinated pregnant women and
lactating mothers to allow effective and constant monitoring
of their health;
(v) Setting up of separate vaccination centers to protect this E
class of persons from untoward infection;
(vi) Engaging Anganwadi centres and ASHA workers for
vaccination drives as a method of outreach particularly for
women belonging to underprivileged socio economic
backgrounds; and F
(vii) Providing an option on the Co-WIN portal so as to allow
pregnant women and lactating mothers to classify and
identify themselves such that they can be given priority while
providing slots for vaccination.
2. Initially, a preliminary affidavit was filed on 2 October 2021 by G
the Additional Commissioner in the Union Ministry of Health and Family
Welfare3. The affidavit has detailed out steps taken for (i) constituting
1
“DCPCR”
2
“SOP”
3
“MoHFW” H
910 SUPREME COURT REPORTS [2022] 2 S.C.R.
A the National Technical Advisory Group on Immunization4 and National
Expert Group on Vaccination Administration for Covid-195; (ii) steps
taken for supporting the vaccination of pregnant women; (iii) steps taken
for tracking Adverse Events Following Immunization6; and (iv) support
provided through vaccination centres and ASHA and Anganwadi workers.
The affidavit states that:
B
(i) Initially, pregnant women and lactating mothers were not
eligible for the COVID-19 vaccination as there was no
sufficient evidence regarding its safety and efficacy.
Subsequently, the World Health Organization and other
experts recommended that the benefits of the vaccine for
C this group outweigh its potential risks;
(ii) Based on the recommendations of experts, a national
consultation was held on the subject with representatives
of State Governments, medical colleges, Federation of
Obstetric and Gynecological Societies of India (FOGSI),
D NGOs, among others, to gain consensus on the subject of
vaccinating pregnant women and lactating mothers and
spreading awareness regarding the vaccination drive;
(iii) The MoHFW approved the vaccination of pregnant women
on 2 July 2021 and vaccination for lactating mothers was
E approved on 19 May 2021. Operational guidelines for
vaccination of pregnant women were released on 2 July
2021, which recommended that all pregnant women visiting
for antenatal care should be informed of the risks and benefits
of COVID-19 vaccines and their likely side effects;
F (iv) The MoHFW has directed all States and Union Territories
to engage with professional bodies such as FOGSI, Indian
Medical Association, Indian Academy of Paediatrics,
National Neonatology Forum;
(v) Since the full impact of the vaccines on pregnancy outcomes
G for the woman and the fetus are unclear, all AEFIs are
monitored through a well-structured and robust surveillance
4
“NTAGI”
5
“NEGVAC”
6
H “AEFI”
DELHI COMMISSION FOR PROTECTION OF CHILD RIGHTS v. UNION OF 911
INDIAAND ANOTHER [DR. DHANANJAYA Y CHANDRACHUD, J.]
system. For this purpose, National AEFI Surveillance A
Operational Guidelines and COVID-19 Operational
Guidelines have been formulated;
(vi) A causality assessment is conducted by the designated AEFI
committee and AEFI amongst the beneficiaries of
vaccination are reported by the vaccinator or District B
Immunization Officer through the Co-WIN portal;
(vii) A multi-centric project to study and document the adverse
events occurring in pregnant women vaccinated with the
COVID-19 vaccine is being initiated across the country;
(viii) All pregnant women who are vaccinated are line-listed on C
the Co-WIN portal with their demographic details and any
AEFI reported is also entered on the portal to ensure that a
tracking mechanism is maintained;
(ix) As regards the vaccination drive for pregnant women and
lactating mothers, States/UTs have been advised that they D
may prioritize vaccination through strategies like dedicated
time period for vaccination of pregnant women and lactating
mothers, designate special days for their vaccination, and
identify centres for vaccination of this group;
(x) ASHA and Anganwadi workers form a critical support
E
system as frontline workers by linking the vaccine
beneficiaries and the service providers. Thus, dedicated
Information Education Communication material has been
developed for frontline workers (including ASHA and
Anganwadi workers and vaccinators); and
(xi) An option has been provided on the Co-WIN portal to F
identify a woman as pregnant to ensure the woman can get
vaccinated at the nearest centre.
3. On 3 December 2021, this Court directed the petitioner to
formulate concrete suggestions to strengthen the existing framework of
vaccination of pregnant women and lactating mothers and share it with G
the Union Government. The petitioner shared these suggestions and
thereafter, a further affidavit dated 13 January 2022 has been filed by
the Union Government which has particularly dealt with AEFIs and the
mechanism for identification of pregnant women and lactating mothers,
in response to the petitioner’s suggestions. The affidavit states that: H
912 SUPREME COURT REPORTS [2022] 2 S.C.R.
A (i) Regarding the declaration and identification of pregnant
women and lactating mothers at the time of vaccination,
only a verbal declaration, on a purely voluntary basis, is
required regarding the status of pregnancy/lactation, which
can be verified at the time of vaccination. Once the
declaration is made, the vaccinator provides the beneficiary
B
with information about risks of COVID-19 infection in
pregnancy, the benefits and side-effects of vaccination;
(ii) The guidelines issued by MoHFW require reporting of any
suspected AEFI irrespective of the time interval between
the day of vaccination and the day of onset of symptoms.
C Thus, there is no time limitation for reporting AEFIs;
(iii) The current AEFI surveillance system collects data of all
adverse events related to COVID-19 vaccine beneficiaries,
including pregnant women or lactating mothers. Under this
system, (a) the District Immunization Officers have been
D instructed to set up a network with private hospitals to report
AEFIs; (b) training has been given to State officers, medical
officers, private practitioners and frontline health workers
on their role in AEFI surveillance; (c) Auxiliary Nurse
Midwifes at block/planning unit have been instructed to
E notify all AEFIs and medical officers have been instructed
to look for any patterns; (d) pregnant women are being
given antenatal care services through government or private
health care facilities;
(iv) Medical treatment is being provided free of cost to
F beneficiaries who suffer AEFIs in all government health
institutions. States/UTs have been asked to identify at least
one AEFI management centre in each block. Additionally,
MoHFW has established a patient to doctor telemedicine
platform;
G (v) Regarding the publication of data, the affidavit states that
once the causality assessment is done, the data regarding
AEFIs is made available in public domain on the website of
MoHFW. Since all AEFIs following vaccination may not
be causally linked to the vaccination, publication of data
without causality assessment is inappropriate as it may
H increase vaccination hesitancy; and
DELHI COMMISSION FOR PROTECTION OF CHILD RIGHTS v. UNION OF 913
INDIAAND ANOTHER [DR. DHANANJAYA Y CHANDRACHUD, J.]
(vi) Regarding the creation of the specific filter on the Co-WIN A
portal for pregnant women and lactating mothers, the
affidavit states that this group has to be identified and
counselled before the vaccination and there is no method
of verification at the time of booking of slots.
4. We have heard Ms Vrinda Grover, learned counsel appearing B
on behalf of the petitioner and Ms Aishwarya Bhati, learned Additional
Solicitor General. An intervention application has been filed by Mr Ambar
H Koiri, who is represented by Mr Nilesh Ojha.
5. During the course of her submissions, Ms Vrinda Grover, learned
counsel has submitted that the affidavits which have been filed by the C
Union of India would substantially resolve the concerns which have been
raised in the petition. Learned counsel submitted that DCPCR instituted
these proceedings with the object of ensuring that vaccination for
pregnant women and lactating mothers is taken up on a priority.
6. The decision to enable vaccination for lactating mothers was D
taken on 19 May 2021 while the decision to permit vaccination for
pregnant women was announced on 2 July 2021. The Court has been
apprised of the fact that in taking these decisions, the Government has
been guided by its own expert groups as well as by a consensus which
has evolved at the international level through the World Health
Organization. E
7. Learned counsel appearing on behalf of the petitioners has
highlighted three concerns which, according to the petitioners, remain
and which may be addressed at a suitable level by the government. We
shall outline the concerns which have been presented during the course
of the oral submissions by Ms Vrinda Grover, seriatim: F
Firstly, it has been submitted that the framework for vaccination
of pregnant women and lactating mothers envisages a voluntary verbal
declaration by the person who seeks vaccination, at the time of registration.
In this context, it has been submitted that the woman who visits a
vaccination centre may not necessarily be aware of the need to make G
such a declaration and in the event that she is not informed by the
personnel at the vaccination centre, the recording of her status either as
a pregnant woman or lactating mother may remain to be incorporated in
the data set. Hence, it has been submitted that if the Co-WIN portal is
suitably modified so as to incorporate a declaration at the time of
H
914 SUPREME COURT REPORTS [2022] 2 S.C.R.
A registration, this would facilitate the monitoring of the health of the
vaccinated woman or mother, as the case may be.
Secondly, it has been suggested that in order to further support
the surveillance measures which have been instituted by the government
for monitoring AEFIs, targeted tracking of pregnant women and lactating
B mothers can be considered so as to bolster the process of monitoring.
Thirdly, it has been emphasized that when adequate data sets
become available, the publication of data will enhance the confidence in
the process of vaccination.
8. Ms Aishwarya Bhati, learned Additional Solicitor General while
C responding to the above suggestions submitted that each of the three
suggestions has been carefully evaluated by experts within the Union
Government. The Additional Solicitor General submits that in the ongoing
process where decisions are being continuously evolved, the government
has certain concerns over implementing the suggestions at the present
D stage but, is open to further deliberation with the expert bodies.
9. On the first aspect in particular, it has been submitted that with
the process of walk-in-registration, the registration on the Co-WIN portal
has become subsidiary. However, it has been submitted that the reason
why it was believed that a verbal declaration at the time of vaccination
E would suffice was to ensure that no person is dissuaded from seeking
vaccination by introducing an additional column at the time of registration.
On targeted tracking, it has been submitted that a robust mechanism has
already been put into place by the Union Government. As regards the
publication of data, it has been submitted that at this stage, such a proposal
may be premature, but the Union Government is seized of the issue.
F Moreover, it has been submitted that the publication of raw data may not
be appropriate and the data is published after due scrutiny and assessment
by experts.
10. This Court is cognizant that the suggestions which have been
made on behalf of the petitioners do raise issues of policy. For instance,
G any mandate for disclosure at the stage of registration has to factor in
and balance concerns over the privacy of the person. There may well
not be one answer or a single acceptable solution particularly because
pregnant women and lactating mothers belong to different social and
economic strata. The government has to take a decision bearing mind
their welfare, safety and dignity. Likewise, the need to further enhance
H
DELHI COMMISSION FOR PROTECTION OF CHILD RIGHTS v. UNION OF 915
INDIAAND ANOTHER [DR. DHANANJAYA Y CHANDRACHUD, J.]
the existing protocols for monitoring AEFIs can be carefully evaluated A
by the expert groups. The Additional Solicitor General has already stated
that data is placed in the public domain after being scrutinized at an
expert level within the government. The suggestions made before the
Court have emanated from a statutory body. They can be considered
with the same sense of cooperation which has pervaded the judicial
B
process during the hearing of the present petition.
11. The three suggestions which have been made by the petitioners
would undoubtedly involve an application of domain knowledge by experts
in the area. The Court may not be in the best position to take a decision
unaided by an expert determination. Hence, we are of the view that
having regard to the inclination which has been shown by the Union C
Government, it would be appropriate if the three suggestions which have
been outlined earlier are duly placed before the concerned expert groups
as set out in the affidavit of the Union Government so that the suggestions
can be deliberated upon at a policy level at an appropriate stage. This
Court has constituted a National task Force previously comprised of D
eminent experts from across the country and the Union Government
may engage with them as well to seek suggestions for eliciting its views
and suggestions in the area. We appreciate the steps which have been
taken by DCPCR in moving these proceedings and equally, the sense of
responsibility with which suggestions have been made and discussed
both by Ms Vrinda Grover appearing for DCPCR and by Ms Aishwarya E
Bhati, Additional Solicitor General appearing for the Union Government
in the course of these proceedings.
12. Leaving it open to the Union of India to take a considered
view after evaluating the suggestions, we dispose of the petition.
F
13. We further note that Mr Nilesh Ojha, counsel appearing on
behalf of the intervenor, has urged before this Court that the intervenor
has conducted studies which reflect that COVID-19 vaccines pose a
risk to pregnant women or the fetus. On this basis, the intervenor has
sought a direction from this Court to stop the administration of vaccination
to pregnant women. The issues raised by the intervenor clearly lie in the G
policy domain and this Court cannot take medical decisions regarding
the safety of COVID-19 vaccination among pregnant and lactating
persons. The affidavits of the Union of India indicate that NTAGI and
NEGVAC have taken great care in recommending vaccination for these
groups only after receiving guidance from the World Health Organization H
916 SUPREME COURT REPORTS [2022] 2 S.C.R.
A and other domain experts. Thus, we do not find it necessary to issue any
directions to the Union Government as regards this intervention
application.
14. Pending applications, if any, stand disposed of.
B Devika Gujral Petition disposed of.
(Assisted by : Mahendra Yadav, LCRA)
C
D
E
F
G
H
Search Indian case law
Ask in plain English, not just keywords. 25,000 AI words free, no card.